View Filing Data

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	May 10, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	Semler Scientific, Inc.
Entity Central Index Key	0001554859
Trading Symbol	smlr
Current Fiscal Year End Date	--03-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		5,313,568
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Amendment Flag	false
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Revenue	$ 2,055	$ 1,501
Operating expenses:
Cost of revenue	540	417
Engineering and product development	439	270
Sales and marketing	988	974
General and administrative	838	772
Total operating expenses	2,805	2,433
Loss from operations	(750)	(932)
Interest expense	(116)	(73)
Other expense	(5)	(1)
Other expense	(121)	(74)
Net loss	$ (871)	$ (1,006)
Net loss per share, basic and diluted (in dollars per share)	$ (0.17)	$ (0.20)
Weighted average number of shares used in computing basic and diluted loss per share (in shares)	5,231,208	5,123,568

Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash	$ 159	$ 622
Trade accounts receivable, net of allowance for doubtful accounts of $83 and $87, respectively	1,181	877
Prepaid expenses and other current assets	117	93
Total current assets	1,457	1,592
Assets for lease, net	1,098	875
Property and equipment, net	546	590
Long-term deposits	15	15
Total assets	3,116	3,072
Current liabilities:
Accounts payable	310	450
Accrued expenses	2,332	2,185
Deferred revenue	793	513
Deferred rent	17
Accrued interest	73
Accrued interest - related party	151
Loans payable net of debt discount of $38 and $0, respectively	721	81
Related party loans payable net of debt discount of $95 and $0, respectively	1,405
Total current liabilities	5,802	3,229
Long-term liabilities:
Deferred rent, less current portion	13	35
Accrued interest, less current portion	22	71
Accrued interest - related parties, less current portion	10	124
Loans payable net of debt discount of $13 and $65, respectively, less current portion	281	938
Related party loans payable net of debt discount of $24 and $156, respectively, less current portion	226	1,594
Total long-term liabilities	552	2,762
Stockholders' deficit:
Common stock, $0.001 par value; 50,000,000 shares authorized; 5,338,568 and 5,148,568 shares issued, and 5,313,568 and 5,123,568 outstanding (treasury shares of 25,000 and 25,000), respectively	5	5
Additional paid-in capital	22,550	21,998
Accumulated deficit	(25,793)	(24,922)
Total stockholders' deficit	(3,238)	(2,919)
Total liabilities and stockholders' deficit	$ 3,116	$ 3,072

Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Allowance for doubtful accounts on trade accounts receivable (in dollars)	$ 83	$ 87
Loans payable net of debt discount current	38	0
Related party loans payable net of debt discount, current	95	0
Loans payable net of debt discount noncurrent	13	65
Related party loans payable net of debt discount, noncurrent	$ 24	$ 156
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	5,338,568	5,148,568
Common stock, shares outstanding	5,313,568	5,123,568
Treasury stock, shares	25,000	25,000

Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (871)	$ (1,006)
Reconciliation of Net Loss to Net Cash Used in Operating Activities:
Amortization of debt discount	51	36
Depreciation	134	110
Loss on disposal of assets for lease	88	55
Allowance for doubtful accounts	4	(6)
Stock-based compensation expense	78	69
Changes in Operating Assets and Liabilities:
Trade accounts receivable	(308)	685
Prepaid expenses and other current assets	(24)	(83)
Accounts payable	(140)	(449)
Accrued expenses	203	(485)
Deferred revenue	280	(19)
Net Cash Used in Operating Activities	(505)	(1,093)
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property and equipment	(3)	(6)
Purchase of assets for lease	(399)	(65)
Net Cash Used in Investing Activities	(402)	(71)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	475
Proceeds from loans payable		2,200
Payments of loans payable	(31)
Net Cash Provided by Financing Activities	444	2,200
(DECREASE) INCREASE IN CASH	(463)	1,036
CASH, BEGINNING OF PERIOD	622	405
CASH, END OF PERIOD	159	1,441
Cash paid for interest	$ 3
Supplemental disclosure of noncash financing activity:
Fair value of warrants issued to lenders		$ 349

Basis of Presentation

3 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Basis of Presentation

1.	Basis of Presentation

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 17, 2017 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers. The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. This standard is effective for the Company’s quarter ending March 31, 2018. Since the issuance of ASU 2014-09, the FASB has issued several amendments which clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. The Company will adopt the new standard in the first quarter of fiscal year 2018. The Company is currently evaluating the method of adoption and effect the new standard will have on its financial statements.

In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This ASU provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a Company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about the company’s ability to continue as a going concern within one year from the date the financial statements are issued. This standard is effective for annual periods ending after December 15, 2016, and for interim periods within annual periods beginning after December 15, 2016 with early adoption permitted. The Company adopted the new standard in the first quarter of fiscal year 2017. The adoption of this standard has not had a material impact on its financial statements.

In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes, to reduce complexity and simplify the reporting of deferred income tax liabilities and assets. Current GAAP requires an entity to separate deferred income tax liabilities into current and noncurrent amounts in a classified balance sheet. The amendments in this update require that deferred tax liabilities and assets be classified as noncurrent in a classified balance sheet. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendment of this Update. This standard is effective for the Company’s annual periods beginning after December 15, 2017 and interim periods within annual periods beginning after December 15, 2018. The Company will adopt the new standard in fiscal year 2018. The Company maintains full valuation allowances on all deferred tax balances, and therefore, the adoption of this standard is not anticipated to have a material impact on its financial statements.

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

In March 2016, the FASB has issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting ("ASU No. 2016-09"). The amendments in ASU No. 2016-09 are intended to simplify several aspects of the accounting for employee share-based payment transactions including requiring excess benefits and deficiencies to be recognized as a component of income tax expense rather than equity, allowing an entity to make an accounting policy election to either estimate expected forfeitures or to account for them as they occur, and classification of certain items in the statement of cash flows. The standard is effective for Company’s annual periods beginning after December 15, 2016, including interim periods within those annual periods, with early adoption permitted. The Company adopted this standard in the first quarter of fiscal year 2017. The adoption of this standard did not have a material impact on its financial statements.

Going Concern

3 Months Ended

Mar. 31, 2017

Going Concern [Abstract]

Going Concern

2.	Going Concern

The Company has incurred recurring losses since inception and expects to continue to incur losses as a result of costs and expenses related to the Company’s marketing and other promotional activities, as well as continued research and development of its products. As of March 31, 2017, the Company has negative working capital of $4,345, cash of $159 and stockholders’ deficit of $3,238. The Company’s principal sources of cash have included the issuance of equity securities, and to a lesser extent, borrowings under loan agreements and revenue from leasing its product. To increase revenue, the Company’s operating expenses will continue to grow and, as a result, the Company will need to generate significant additional revenues to achieve profitability. The Company also had $2,332 of accrued expenses as of March 31, 2017, which includes an aggregate of $1,867 of deferred fees and compensation payable no later than January 1, 2018.

The Company’s financial statements as of March 31, 2017 have been prepared under the assumption that the Company will continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to attain further operating efficiencies and, ultimately, to generate additional revenue. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company can give no assurances that additional capital that the Company is able to obtain, if any, will be sufficient to meet the Company’s needs. The foregoing conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Assets for Lease, net

3 Months Ended

Mar. 31, 2017

Leases, Capital [Abstract]

Assets for Lease, net

3.	Assets for Lease, net

Assets for lease consist of the following:

	March 31, 2017			December 31, 2016

Assets for lease	$	1,608		$	1,361
Less: accumulated depreciation		(510	)		(486	)
Assets for lease, net	$	1,098		$	875

Depreciation expense amounted to $87 and $80 for the three months ended March 31, 2017 and March 31, 2016, respectively. Reduction to accumulated depreciation for returned items was $49 and $29 for the three months ended March 31, 2017 and March 31, 2016, respectively.

Property and Equipment, net

3 Months Ended

Mar. 31, 2017

Property, Plant and Equipment [Abstract]

Property and Equipment, net

4.	Property and Equipment, net

Capital assets consist of the following:

	March 31, 2017			December 31, 2016

Capital assets	$	763		$	760
Less: accumulated depreciation		(217	)		(170	)
Capital assets, net	$	546		$	590

Depreciation expense amounted to $47 and $30 for the three months ended March 31, 2017 and 2016, respectively.

Accrued Expenses

3 Months Ended

Mar. 31, 2017

Accrued Liabilities, Current [Abstract]

Accrued Expenses

5.	Accrued Expenses

Accrued expenses consist of the following:

	March 31, 2017		December 31, 2016

Offering costs⁽¹⁾	$	232	$	227
Compensation⁽²⁾		1,501		1,481
Board of directors fees⁽³⁾		134		191
Miscellaneous accruals		465		286
Total accrued expenses	$	2,332	$	2,185

(1) Accumulated offering costs accrued pertain to consulting fees associated with securing equity financing for the Company prior to the initial public offering. Prior to becoming Chief Executive Officer (“CEO”), the Company’s current CEO performed consulting services for the Company, which included managing finance, sales, marketing, operational and strategic planning for the Company, as well as assistance and strategic guidance in securing financing. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to be paid no later than January 1, 2018.

(2) Three employees agreed to further defer amounts accrued to them as of December 31, 2016. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to be paid no later than January 1, 2018.

(3) Two members of the Company’s board of directors agreed to further defer fees earned from August 2016 to July 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to be paid no later than January 1, 2018.

Commitments and Contingencies

3 Months Ended

Mar. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

6.	Commitments and Contingencies

Facilities Leases

The Company recognized facilities lease expenses of $17 and $15 for the three months ended March 31, 2017 and 2016, respectively.

On September 23, 2014, the Company entered into a 36-month lease agreement for office space for the sales and marketing team located in Menlo Park, CA. The lease term commenced February 1, 2015 and is effective through January 31, 2018. Payments required under the terms of the lease are $17.0 per month from February 2015 to January 2016, $17.5 per month from February 2016 to January 2017, and $18.0 per month from February 2017 to January 2018. The Company anticipates total future lease payments of $162.0 for the year ended December 31, 2017; and $18.0 for the year ended December 31, 2018. On July 15, 2015, the Company

entered into a 30-month sublease agreement for the Menlo Park office space, which commenced August 1, 2015 and is effective through the term of the lease, January 31, 2018. Payments required to the Company under the terms of the sublease are $15.5 per month from August 2015 to July 2016, $16.0 per month from August 2016 to July 2017, and $16.5 per month from August 2017 to January 2018. The Company anticipates receipt of total future sublease payments of $146.4 for the year ended December 31, 2017; and $16.5 for the year ended December 31, 2018. As of March 31, 2017, the Company recorded the resulting short-term liability as deferred rent of $17 on the Company’s balance sheet. As of December 31, 2016, the Company recorded the resulting long-term liability as deferred rent of $35 on the Company’s balance sheet.

Loans Payable

	March 31, 2017
Lender	Long-term			Short-term
Loans from Related Parties
Chang Family Trust					1,000
Chang Family Trust					500
Glenhill Concentrated Long Master Fund, LLC		250

Other Loans
Accredited Investor					700
Accredited Investor		160
Accredited Investor		80
Ascentium Capital, LLC					15
Ascentium Capital, LLC		36			25
Royal Bank America Leasing, L.P.					9
Ascentium Capital, LLC		18			10

Total		544			2,259
Debt Discounts		(37	)		(133	)
Total, net of debt discounts		507			2,126

Loans from Related Parties

On January 15, 2016, the Company entered into a loan agreement with the Chang Family Trust, one of its significant stockholders, is co-trustee. Pursuant to the loan agreement, the Company obtained a $1,000 unsecured loan for a 24-month term at a fixed interest rate of 10% p.a. Under the loan agreement, the Company will pay $1,000 of principal plus all accrued and unpaid interest at maturity. The Company may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and the Company agreed not to incur additional indebtedness in excess of $50 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, the Company issued the Chang Family Trust a two-year warrant to purchase 114,286 shares of its common stock at an exercise price of $1.75 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 19.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan.

On January 21, 2016, the Company entered into a second loan agreement with the Chang Family Trust. Pursuant to this loan agreement, the Company obtained a $500 unsecured loan for a 24-month term at a fixed interest rate of 5% p.a. Under this loan agreement, the Company will pay $500 of principal plus all accrued and unpaid interest at maturity. The Company may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and the Company agreed not to incur additional indebtedness in excess of $50 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, the Company issued the Chang Family Trust a two-year warrant to purchase 114,286 shares of its common stock at an exercise price of $1.75 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 19.99% of the Company’s common stock. The

relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan.

On November 21, 2016, the Company entered into a loan agreement with Glenhill Concentrated Long Master Fund, LLC, one of its significant stockholders. Pursuant to the loan agreement, the Company obtained a $250 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $250 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 28,378 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan.

Other Loans

On March 31, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $700 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $700 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 79,459 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan.

On April 5, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $160 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $160 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 18,162 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan.

On May 20, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $80 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $80 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 9,081 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan.

The Company uses the Black-Scholes pricing model to determine the fair value of warrants. The fair value of each warrant is estimated on the date of grant. There were no warrants issued during the three months ended March 31, 2017. The fair value of all warrants issued in conjunction with the promissory notes during 2016 was $407. The fair value of the warrants granted is estimated on the date of grant using the Black-Scholes pricing model and the following assumptions for the periods presented:

	Three months ended March 31,
	2017			2016
Expected term (in years)		-			2
Risk-free interest rate		-	%		0.76 – 0.88	%
Expected volatility		-	%		79.0 – 98.6	%
Expected dividend rate.		-	%		0	%

The assumptions are based on the following for each of the years presented:

Valuation Method — The Company estimates the fair value of warrants using the Black-Scholes pricing model.

Expected Term — The Company uses the amount of time the warrants are exercisable per the contractual terms of the award.

Volatility — The Company derives this number from the historical stock volatility of the Company’s stock over a period approximately equal to the expected term of the warrants.

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the warrants.

Expected Dividend — The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.

On July 1, 2016, the Company entered into a software license financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $39 loan for a 12-month term at a fixed interest rate of 8.9% per annum. to finance its upfront software licensing fee. The Company has no obligation to make any payments during the first three months, and agreed to pay $4.6 of principal and accrued interest for each of the last 9 months of the term. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.

On July 8, 2016, the Company entered into an additional software license financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $74 loan for a 36-month term at a fixed interest rate of 8.9% per annum. Under the loan agreement, the Company agreed to make monthly payments of $2.4 of principal and accrued interest. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.

On July 11, 2016, the Company entered into a secured equipment financing agreement with Royal Bank America Leasing, L.P. Pursuant to the agreement, the Company obtained a $140 loan for a 36-month term at a fixed interest rate of 7.3% per annum, which is secured by related equipment. The loan is to be disbursed in three installments. The first installment was for $37. The second installment for $47 will be disbursed in July 2017, and the third installment for $56 will be disbursed in July 2018. Under the loan agreement, the Company will pay $3.5 of principal and accrued interest for each of the first 12 months, $4.4 of principal and accrued interest for each of months 13-24, and $5.3 of principal and accrued interest for each of months 25-36. The loan may be prepaid at any time only in accordance with the agreement. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.

On October 2, 2016, the Company entered into a secured equipment financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $33 loan for a 36-month term at a fixed interest rate of 9.1% per annum. Under the loan agreement, the Company agreed to make monthly payments of $1.0 of principal and accrued interest. The loan may be

prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.

For the three months ended March 31, 2017 and 2016, interest expense was $116 and $73, respectively, which included amortization of the debt discount of $51 and $36, respectively.

Indemnification Obligations

The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payments under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.

Net Loss Per Common Share

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Net Loss Per Common Share

7.	Net Loss Per Common Share

Because the Company was in a loss position for each of the periods presented, diluted net loss per share is the same as basic net loss per share for each period as the inclusion of all potential common shares outstanding would have been anti-dilutive. The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:

	Three months ended March 31,
	2017		2016
Weighted average shares outstanding:
Common stock warrants		751,366		573,111
Options		2,044,184		1,984,578
Total		2,795,550		2,557,689

Stock Option Plan

3 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Option Plan

8.	Stock Option Plan

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share

Reserve increased by 204,943 shares due to the automatic 4% increase. The Share Reserve is currently 2,548,526 shares for the year ending December 31, 2016.

In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of March 31, 2017, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 876,875 shares of an aggregate total of 2,548,526 shares were available for future stock-based compensation grants under the 2014 Plan.

Aggregate intrinsic value represents the difference between the closing market value as of March 31, 2017 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the three months ended March 31, 2017 is as follows:

	Options Outstanding
	Number of Stock Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value (in thousands)
Balance, January 1, 2017		2,049,517		$	2.58		7.66	$	306
Options granted		170,000			1.97
Options exercised		-			-
Options forfeited/canceled		(155,417	)		3.46
Balance, March 31, 2017		2,064,100		$	2.47		7.57	$	923
Exercisable as of March 31, 2017		1,531,673		$	2.51		7.13	$	740

The total compensation cost related to unvested stock option awards not yet recognized was $844 as of March 31, 2017. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 2.98 years. The estimated fair value of option shares vested during the quarters ended March 31, 2017 and 2016 was $78 and $69, respectively. The weighted average fair value of options granted during the quarters ended March 31, 2017 and 2016 was $1.52 and $1.43 per share, respectively, or an aggregate grant date fair value of $258 and $229, respectively.

On January 20, 2017 the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 20, 2016 the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 15,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date.

Determining the Fair Value of Stock Options

The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. The following assumptions for the periods presented were:

	Three months ended March 31,
	2017			2016
Expected term (in years)		5			5
Risk-free interest rate		1.95 – 2.02	%		1.21	%
Expected volatility		1.04 – 1.06	%		80.4	%
Expected dividend rate.		0	%		0	%

The assumptions are based on the following for each of the periods presented:

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

Expected Term — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.

Volatility — Because the Company has limited trading history by which to determine the volatility of its own common stock price, the expected volatility being used is derived from the historical stock volatilities of a representative industry peer group of comparable publicly listed companies over a period approximately equal to the expected term of the options.

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

Forfeiture — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09 as described in Note 1, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.

The Company has recorded an expense of $78 and $69 as it relates to stock-based compensation for the three months ended March 31, 2017 and 2016, respectively:

	Three months ended March 31,
	2017		2016
Cost of Revenue	$	1	$	1
Engineering and Product Development		12		13
Sales and Marketing		21		25
General and Administrative		44		30
Total	$	78	$	69

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

Issuance of Common Stock

3 Months Ended

Mar. 31, 2017

Stockholders' Equity Note [Abstract]

Issuance of Common Stock

9.	Issuance of Common Stock

On January 23, 2017, the Company issued and sold 40,000 shares of its common stock to Glenhill Concentrated Long Master Fund, LLC, one of its significant stockholders, pursuant to a stock purchase agreement for $100,000, which was paid in cash. On February 13, 2017, the Company issued and sold an aggregate of 150,000 shares of its common stock to two accredited investors, including GPG RM Investment, LLC, an affiliate of one of its significant stockholders, pursuant to separate stock purchase agreements for an aggregate purchase price of $375,000, which was paid in cash.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

Subsequent Events

3 Months Ended

Mar. 31, 2017

Subsequent Events [Abstract]

Subsequent Events

10.

Subsequent Events

On May 2, 2017, the Company entered into an amendment to certain outstanding promissory notes issued in January 2016 having an aggregate principal amount of $1.5 million and certain outstanding warrants to acquire an aggregate 228,572 shares of its common stock issued in connection with such notes, in each case held by the Chang Family Trust, one of its significant stockholders. As amended, the maturity date for each note has now been extended by 12 months, and the interest rate on the $500,000 note has been increased to 10.0% for the final 12 months of its term. In each case, interest will accrue on the unpaid principal and accrued interest as of the original two-year maturity date in the final year term of the notes. The other terms of the notes remain unchanged. Additionally, as issued, the warrants were not exercisable, absent receipt of stockholder approval, if after such exercise the holder would be the beneficial owner of more than 19.99% of the Company’s common stock. This condition was removed by the amendments, and accordingly, stockholder approval is no longer required. In connection with the foregoing amendment, the Company issued the Chang Family Trust a warrant to purchase 134,616 shares of its common stock at an exercise price of $2.60 per share. The warrant expires January 21, 2022, three years after the latest maturity date of the promissory notes, as amended.

Summary of Significant Accounting Policies and Estimates (Policies)

3 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Assets for lease, net (Tables)

3 Months Ended

Mar. 31, 2017

Leases, Capital [Abstract]

Schedule of assets for lease

	March 31, 2017			December 31, 2016

Assets for lease	$	1,608		$	1,361
Less: accumulated depreciation		(510	)		(486	)
Assets for lease, net	$	1,098		$	875

Property and Equipment, net (Tables)

3 Months Ended

Mar. 31, 2017

Property, Plant and Equipment [Abstract]

Schedule of property and equipment

	March 31, 2017			December 31, 2016

Capital assets	$	763		$	760
Less: accumulated depreciation		(217	)		(170	)
Capital assets, net	$	546		$	590

Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2017

Accrued Liabilities, Current [Abstract]

Schedule of accrued expenses

	March 31, 2017		December 31, 2016

Offering costs⁽¹⁾	$	232	$	227
Compensation⁽²⁾		1,501		1,481
Board of directors fees⁽³⁾		134		191
Miscellaneous accruals		465		286
Total accrued expenses	$	2,332	$	2,185

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Loans Payable

	March 31, 2017
Lender	Long-term			Short-term
Loans from Related Parties
Chang Family Trust					1,000
Chang Family Trust					500
Glenhill Concentrated Long Master Fund, LLC		250

Other Loans
Accredited Investor					700
Accredited Investor		160
Accredited Investor		80
Ascentium Capital, LLC					15
Ascentium Capital, LLC		36			25
Royal Bank America Leasing, L.P.					9
Ascentium Capital, LLC		18			10

Total		544			2,259
Debt Discounts		(37	)		(133	)
Total, net of debt discounts		507			2,126

Schedule of relative fair value of the warrants granted using the Black-Scholes pricing model

	Three months ended March 31,
	2017			2016
Expected term (in years)		-			2
Risk-free interest rate		-	%		0.76 – 0.88	%
Expected volatility		-	%		79.0 – 98.6	%
Expected dividend rate.		-	%		0	%

Net Loss Per Common Share (Tables)

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Schedule of common stock equivalents excluded from the computation of diluted net loss per share

	Three months ended March 31,
	2017		2016
Weighted average shares outstanding:
Common stock warrants		751,366		573,111
Options		2,044,184		1,984,578
Total		2,795,550		2,557,689

Stock Option Plan (Tables)

3 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of summary of stock-based compensation activity

	Options Outstanding
	Number of Stock Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value (in thousands)
Balance, January 1, 2017		2,049,517		$	2.58		7.66	$	306
Options granted		170,000			1.97
Options exercised		-			-
Options forfeited/canceled		(155,417	)		3.46
Balance, March 31, 2017		2,064,100		$	2.47		7.57	$	923
Exercisable as of March 31, 2017		1,531,673		$	2.51		7.13	$	740

Schedule of weighted-average Black-Scholes fair value assumptions

	Three months ended March 31,
	2017			2016
Expected term (in years)		5			5
Risk-free interest rate		1.95 – 2.02	%		1.21	%
Expected volatility		1.04 – 1.06	%		80.4	%
Expected dividend rate.		0	%		0	%

Schedule of stock-based compensation based on the role and responsibility of the recipient in the Company

	Three months ended March 31,
	2017		2016
Cost of Revenue	$	1	$	1
Engineering and Product Development		12		13
Sales and Marketing		21		25
General and Administrative		44		30
Total	$	78	$	69

Going Concern (Detail Textuals) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Going Concern [Abstract]
Working capital deficit	$ 4,345
Cash	159	$ 622	$ 1,441	$ 405
Stockholders' deficit	(3,238)	(2,919)
Accrued expenses	2,332	$ 2,185
Accrued deferred fees	$ 1,867

Assets for Lease, net - Summary of assets for lease (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Leases, Capital [Abstract]
Assets for lease	$ 1,608	$ 1,361
Less: Accumulated depreciation	(510)	(486)
Assets for lease, net	$ 1,098	$ 875

Assets for Lease, net (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Leases, Capital [Abstract]
Depreciation expense	$ 87	$ 80
Reduction to accumulated depreciation for returned items	$ 49	$ 29

Property and Equipment, net (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property and equipment	$ 763	$ 760
Less: accumulated depreciation	(217)	(170)
Capital assets, net	$ 546	$ 590

Property and Equipment, net (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 47	$ 30

Accrued Expenses - Summary of accrued expenses (Details) - USD ($)
$ in Thousands

Mar. 31, 2017

Dec. 31, 2016

Accrued Liabilities, Current [Abstract]

Offering Costs

^[1]

$ 232

$ 227

Compensation

^[2]

1,501

1,481

Board of directors fees

^[3]

134

191

Miscellaneous Accruals

465

286

Total Accrued Expenses

$ 2,332

$ 2,185

[1]	Accumulated offering costs accrued pertain to consulting fees associated with securing equity financing for the Company prior to the initial public offering. Prior to becoming Chief Executive Officer ("CEO"), the Company's current CEO performed consulting services for the Company, which included managing finance, sales, marketing, operational and strategic planning for the Company, as well as assistance and strategic guidance in securing financing. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to be paid no later than January 1, 2018.
[2]	Three employees agreed to further defer amounts accrued to them as of December 31, 2016. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to be paid no later than January 1, 2018.
[3]	Two members of the Company's board of directors agreed to further defer fees earned from August 2016 to July 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to be paid no later than January 1, 2018.

Accrued Expenses (Details textuals)	3 Months Ended
Accrued Expenses (Details textuals)	Mar. 31, 2017
Accrued Liabilities, Current [Abstract]
Percentage increase in balance owe	1.00%

Commitments and Contingencies (Detail) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Line of Credit Facility [Line Items]
Related Party, Total, net of debt discounts	$ 226	$ 1,594
Long-term, Total	544
Long-term, Debt Discounts	(37)
Long-term, Total, net of debt discounts	507	938
Short-term, Total	2,259
Short-term, Debt Discounts	(133)
Short-term, Total, net of debt discounts	2,126	$ 81
Chang Family Trust
Line of Credit Facility [Line Items]
Short-term, Total	1,000
Chang Family Trust
Line of Credit Facility [Line Items]
Short-term, Total	500
Glenhill Concentrated Long Master Fund, LLC
Line of Credit Facility [Line Items]
Long-term, Total	250
Accredited investor
Line of Credit Facility [Line Items]
Short-term, Total	700
Accredited Investor
Line of Credit Facility [Line Items]
Long-term, Total	160
Accredited Investor
Line of Credit Facility [Line Items]
Long-term, Total	80
Ascentium Capital, LLC
Line of Credit Facility [Line Items]
Short-term, Total	15
Ascentium Capital, LLC
Line of Credit Facility [Line Items]
Long-term, Total	36
Short-term, Total	25
Royal Bank America Leasing, L.P.
Line of Credit Facility [Line Items]
Short-term, Total	9
Ascentium Capital, LLC
Line of Credit Facility [Line Items]
Long-term, Total	18
Short-term, Total	$ 10

Commitments and Contingencies (Details 1)	3 Months Ended
Commitments and Contingencies (Details 1)	Mar. 31, 2017	Mar. 31, 2016
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected term (in years)		2 years
Risk-free interest rate
Expected volatility
Expected dividend rate		0.00%
Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-free interest rate		0.76%
Expected volatility		79.00%
Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-free interest rate		0.88%
Expected volatility		98.60%

Commitments and Contingencies (Detail Textuals) - USD ($)		1 Months Ended	3 Months Ended
	Jul. 15, 2015	Sep. 23, 2014	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Property Subject to or Available for Operating Lease [Line Items]
Lease expense			$ 17,000	$ 15,000
Deferred rent short-term liability			17,000
Deferred rent long-term liability					$ 35,000
Lease Agreement
Property Subject to or Available for Operating Lease [Line Items]
Term specified for lease agreement		36 months
Future lease payments for December 31, 2017			162,000
Future lease payments for December 31, 2018			18,000
Lease Agreement \| Lease term from February 2015 to January 2016
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			17,000
Lease Agreement \| Lease term from February 2016 to January 2017
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			17,500
Lease Agreement \| Lease term from February 2017 to January 2018
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			18,000
Sub Lease Agreement
Property Subject to or Available for Operating Lease [Line Items]
Term specified for lease agreement	30 months
Future lease payments for December 31, 2017			146,400
Future lease payments for December 31, 2018			16,500
Sub Lease Agreement \| Lease term from August 2015 to July 2016
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			15,500
Sub Lease Agreement \| Lease term from August 2016 to July 2017
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			16,000
Sub Lease Agreement \| August 2017 to January 2018
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			$ 16,500

Commitments and Contingencies (Detail Textuals 1) - USD ($)							1 Months Ended				3 Months Ended
	Oct. 02, 2016	Jul. 11, 2016	Jul. 08, 2016	Jul. 01, 2016	Apr. 05, 2016	Jan. 15, 2016	Nov. 21, 2016	May 20, 2016	Mar. 31, 2016	Jan. 21, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Commitments And Contingencies [Line Items]
Interest expense											$ 116,000	$ 73,000
Amortization of debt discount											$ 51,000	36,000
Fair value of all warrants													$ 407,000
Ascentium Capital, LLC \| Secured equipment financing agreement
Commitments And Contingencies [Line Items]
Secured Debt	$ 33,000
Debt Instrument, Term	36 months
Loan rate of interest	9.10%
loan principal and interest payment	$ 1,000
Fixed interest rate 8.9% \| Ascentium Capital, LLC \| Software license financing agreement
Commitments And Contingencies [Line Items]
Unsecured loan			$ 74,000	$ 39,000
Debt Instrument, Term			36 months	12 months
Loan rate of interest			8.90%	8.90%
loan principal and interest payment			$ 2,400	$ 4,600
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement
Commitments And Contingencies [Line Items]
Unsecured loan		$ 140,000
Debt Instrument, Term		36 months
Loan rate of interest		7.30%
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement \| First installment
Commitments And Contingencies [Line Items]
loan principal and interest payment		$ 37,000
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement \| Second installment
Commitments And Contingencies [Line Items]
loan principal and interest payment		47,000
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement \| Third installment
Commitments And Contingencies [Line Items]
loan principal and interest payment		56,000
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement \| First 12 months
Commitments And Contingencies [Line Items]
loan principal and interest payment		3,500
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement \| Each of months 13-24
Commitments And Contingencies [Line Items]
loan principal and interest payment		4,400
Fixed interest rate 7.3% \| Royal Bank America Leasing, L.P. \| Secured equipment financing agreement \| Each of months 25-36
Commitments And Contingencies [Line Items]
loan principal and interest payment		$ 5,300
Unsecured Debt \| Fixed rate of interest 10%
Commitments And Contingencies [Line Items]
Unsecured loan						$ 1,000,000
Debt Instrument, Term						24 months
Loan rate of interest						10.00%
loan principal and interest payment						$ 1,000,000
Additional indebtedness limit						$ 50,000
Term of warrant						2 years
Number of warrant issued to purchase common stock						114,286
Exercise price per warrants						$ 1.75
Minimum percentage holding required by holder to retain exercising rights						more than 19.99%
Unsecured Debt \| Fixed rate of interest 10% \| Accredited investor
Commitments And Contingencies [Line Items]
Unsecured loan					$ 160,000			$ 80,000	$ 700,000			$ 700,000
Debt Instrument, Term					24 months			24 months	24 months
Loan rate of interest					10.00%			10.00%	10.00%
loan principal and interest payment					$ 160,000			$ 80,000	$ 700,000
Term of warrant					2 years			2 years	2 years
Number of warrant issued to purchase common stock					18,162			9,081	79,459			79,459
Exercise price per warrants					$ 1.85			$ 1.85	$ 1.85			$ 1.85
Minimum percentage holding required by holder to retain exercising rights					more than 4.99			more than 4.99	more than 4.99
Unsecured Debt \| Fixed rate of interest 10% \| Glenhill Concentrated Long Master Fund, LLC
Commitments And Contingencies [Line Items]
Unsecured loan							$ 250,000
Debt Instrument, Term							24 months
Loan rate of interest							10.00%
loan principal and interest payment							$ 250,000
Term of warrant							2 years
Number of warrant issued to purchase common stock							28,378
Exercise price per warrants							$ 1.85
Minimum percentage holding required by holder to retain exercising rights							more than 4.99
Unsecured Debt \| Fixed rate of interest 5%
Commitments And Contingencies [Line Items]
Unsecured loan										$ 500,000
Debt Instrument, Term										24 months
Loan rate of interest										5.00%
loan principal and interest payment										$ 500,000
Additional indebtedness limit										$ 50,000
Term of warrant										2 years
Number of warrant issued to purchase common stock										114,286
Exercise price per warrants										$ 1.75
Minimum percentage holding required by holder to retain exercising rights										more than 19.99

Net Loss Per Common Share (Details) - shares	3 Months Ended
Net Loss Per Common Share (Details) - shares	Mar. 31, 2017	Mar. 31, 2016
Weighted average shares outstanding:
Total	2,795,550	2,557,689
Common stock warrants
Weighted average shares outstanding:
Total	751,366	573,111
Options
Weighted average shares outstanding:
Total	2,044,184	1,984,578

Stock Option Plan - Summary of stock-based compensation activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Number of Stock Options Outstanding
Balance, January 1, 2017	2,049,517
Options granted	170,000
Options exercised
Forfeited/Cancelled	(155,417)
Balance, March 31, 2017	2,064,100
Exercisable as of March 31, 2017	1,531,673
Weighted Average Exercise Price
Balance, January 1, 2017	$ 2.58
Options granted	1.97
Options exercised
Options forfeited/canceled	3.46
Balance, March 31, 2017	2.47
Exercisable as of March 31, 2017	$ 2.51
Weighted Average Remaining Contractual Term, Options Outstanding (in years)	7 years 6 months 26 days	7 years 7 months 28 days
Weighted Average Remaining Contractual Term, Options Exercisable (in years)	7 years 1 month 17 days
Aggregate Intrinsic Value, Options Outstanding	$ 923	$ 306
Aggregate Intrinsic Value, Options Exercisable	$ 740

Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years	5 years
Risk free interest rate		1.21%
Expected volatility		80.40%
Expected dividend rate	0.00%	0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate	1.95%
Expected volatility	1.04%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate	2.02%
Expected volatility	1.06%

Stock Option Plan - Stock-based compensation (Details 2) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 78	$ 69
Cost of Revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1	1
Engineering and Product Development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	12	13
Sales and Marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	21	25
General and Administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 44	$ 30

Stock Option Plan (Detail Textuals) - USD ($)	1 Months Ended						3 Months Ended
Stock Option Plan (Detail Textuals) - USD ($)	Jan. 31, 2017	Jan. 20, 2017	Jan. 31, 2016	Jan. 20, 2016	Oct. 31, 2015	Jan. 31, 2015	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to non-vested awards							$ 844,000
Weighted average period of unvested stock awards							2 years 11 months 23 days
Total estimated grant date fair value of options vested							$ 78,000	$ 69,000
Weighted average grant date fair value of options granted							$ 1.52	$ 1.43
Aggregate grant date fair value							$ 258,000	$ 229,000
Stock-based compensation expense							$ 78,000	$ 69,000
2007 Key Person Stock Option Plan \| Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants							0
Aggregate number of share reserve							407,500
2014 Stock Incentive Plan \| Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants							876,875
Aggregate number of share reserve							450,000		2,548,526
Maximum term of stock option grants					10 years
Percentage of shares reserve increased	4.00%		4.00%		4.00%	4.00%
Number of share reserve increased	204,943		204,943		1,500,000	188,640
Total estimated grant date fair value of options vested							$ 2,548,526
2014 Stock Incentive Plan \| Stock options \| Board of Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants		125,000
Percentage of shares vested on one year anniversary		25.00%
Number of years in options fully vested		4 years
2014 Stock Incentive Plan \| Stock options \| Non Employee Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants				5,000
Aggregate number of share reserve				15,000
Number of years in options fully vested				1 year

Issuance of Common Stock (Detail Textuals) - Stock Purchase Agreement $ in Thousands		1 Months Ended
	Feb. 13, 2017 USD ($) investor shares	Jan. 23, 2017 USD ($) investor shares
Glenhill Concentrated Long Master Fund, LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock issued \| shares		40,000
Proceeds from issuance of common stock \| $		$ 100,000
Number of investors in stock repurchase programme \| investor		1
Accredited Investors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock issued \| shares	150,000
Proceeds from issuance of common stock \| $	$ 375,000
Number of investors in stock repurchase programme \| investor	2

Subsequent Events (Detail Textuals) - USD ($) $ / shares in Units, $ in Thousands	May 02, 2017	Mar. 31, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Number of common stock issued in connection with notes		5,338,568	5,148,568
Subsequent Event \| Chang Family Trust
Subsequent Event [Line Items]
Promissory note face value	$ 1,500
Common stock called by warrants	228,572
Extended maturity of promissory notes	12 months
Rate of interest charged on specific portion of note	10.00%
Debt Instrument, Term	2 years
Specific portion of notes on which rate of interest increased	$ 500,000
Minimum percentage holding required by holder to retain exercising rights	more than 19.99
Exercise price per warrants	$ 2.6
Number of warrant issued to purchase common stock	134,616
Term of warrant	3 years